nejm tirzepatide osa #Mounjaro/#zepbound (tirzepatide) for obesity complicated by sleep apnea trials presented at #ADA2024 and published in @nejm1️⃣ Participants who were not receiving treatment with positive airway Tirzepatide: A Dual Solution for

Cagrilintide vs Semaglutide: Which GLP-1 Peptide Is Better for Weight Loss

GLP-1 RECEPTOR AGONISTS (GLP-1RAs) may offer potential cardiovascular benefits for people with autoimmune rheumatic diseases (ARDs), according to emerging evidence

This review synthesizes evidence across key mechanistic domains, including endothelial dysfunction, inflammatory signaling, oxidative stress pathways, plaque biology, extracellular matrix remodeling, and immune-cell modulation

And protein is the most important nutrient for combatting such loss

Holst Lange declined to provide more specific data on the differences observed between REDEFINE 1, which was one of two studies that made up the FDA application, and REDEFINE 4, but said the weight loss achievement was similar in both studies

According to Bloomberg , the GLP-1 market could reach $150 billion globally by 2030, driven not just by diabetes care but by the explosive rise in weight management prescriptions